OPC-67683, a Nitro-Dihydro-Imidazooxazole Derivative with Promising Action against Tuberculosis In Vitro and In MiceMakoto Matsumoto, Makoto Komatsu, Hiroyuki Hashizume et al.|PLoS Medicine|2006Cited by 745
Synthesis and Antituberculosis Activity of a Novel Series of Optically Active 6-Nitro-2,3-dihydroimidazo[2,1-<i>b</i>]oxazolesHirofumi Sasaki, Hidetsugu Tsubouchi, Yoshikazu Haraguchi et al.|Journal of Medicinal Chemistry|2006Cited by 177
Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosisMamoru Fujiwara, Makoto Matsumoto, Masanori Kawasaki et al.|Tuberculosis|2017Cited by 163
MIC of Delamanid (OPC-67683) against Mycobacterium tuberculosis Clinical Isolates and a Proposed Critical ConcentrationKelly Wallace Stinson, Lawrence Geiter, Natalia Kurepina et al.|Antimicrobial Agents and Chemotherapy|2016Cited by 57
A Baculovirus Dual Expression System-Based Malaria Vaccine Induces Strong Protection against<i>Plasmodium berghei</i>Sporozoite Challenge in MiceShigeto Yoshida, Makoto Matsumoto, Masanori Kawasaki et al.|Infection and Immunity|2009Cited by 48